[{"address1": "1560 Trapelo Road", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 786 8230", "fax": "781 786 8866", "website": "https://www.dyne-tx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 192, "companyOfficers": [{"maxAge": 1, "name": "Mr. John G. Cox M.B.A.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 1028185, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Oxana  Beskrovnaya Ph.D.", "age": 63, "title": "Chief Innovation Officer", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 719521, "exercisedValue": 2172731, "unexercisedValue": 3736735}, {"maxAge": 1, "name": "Ms. Johanna  Friedl-Naderer", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 748769, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Douglas  Kerr M.B.A., M.D., Ph.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 745640, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Erick J. Lucera C.F.A., C.P.A.", "age": 56, "title": "CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rajesh  Manchanda Ph.D.", "age": 57, "title": "Chief Technical Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James P. Bilotta M.B.A.", "title": "Chief Digital & Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ranjan  Batra Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Wilson", "age": 52, "title": "Senior VP & Head of Legal", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lucia  Celona", "age": 58, "title": "Chief Human Resource Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1751328000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.24, "open": 9.2, "dayLow": 9.0, "dayHigh": 10.23, "regularMarketPreviousClose": 9.24, "regularMarketOpen": 9.2, "regularMarketDayLow": 9.0, "regularMarketDayHigh": 10.23, "payoutRatio": 0.0, "beta": 1.082, "forwardPE": -3.148734, "volume": 2993233, "regularMarketVolume": 2993233, "averageVolume": 2875408, "averageVolume10days": 2511510, "averageDailyVolume10Day": 2511510, "bid": 7.18, "ask": 11.62, "bidSize": 2, "askSize": 2, "marketCap": 1408372608, "fiftyTwoWeekLow": 6.36, "fiftyTwoWeekHigh": 47.45, "fiftyDayAverage": 11.0052, "twoHundredDayAverage": 17.293224, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 476820448, "profitMargins": 0.0, "floatShares": 97923757, "sharesOutstanding": 141544992, "sharesShort": 15730352, "sharesShortPriorMonth": 20621906, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.111099996, "heldPercentInsiders": 0.00509, "heldPercentInstitutions": 0.90966004, "shortRatio": 4.13, "shortPercentOfFloat": 0.1241, "impliedSharesOutstanding": 141544992, "bookValue": 5.887, "priceToBook": 1.6901647, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -367129984, "trailingEps": -3.61, "forwardEps": -3.16, "enterpriseToEbitda": -1.206, "52WeekChange": -0.7676862, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 9.95, "targetHighPrice": 66.0, "targetLowPrice": 9.0, "targetMeanPrice": 39.61765, "targetMedianPrice": 41.0, "recommendationMean": 1.58824, "recommendationKey": "buy", "numberOfAnalystOpinions": 17, "totalCash": 677491968, "totalCashPerShare": 5.96, "ebitda": -395312000, "totalDebt": 23330000, "quickRatio": 19.996, "currentRatio": 20.35, "debtToEquity": 3.487, "returnOnAssets": -0.39922002, "returnOnEquity": -0.64014, "freeCashflow": -176840128, "operatingCashflow": -319724992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "DYN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Dyne Therapeutics, Inc.", "exchange": "NMS", "corporateActions": [], "postMarketTime": 1753486826, "regularMarketTime": 1753473601, "regularMarketChangePercent": 7.68398, "regularMarketPrice": 9.95, "longName": "Dyne Therapeutics, Inc.", "messageBoardId": "finmb_608699906", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1600349400000, "postMarketChangePercent": 1.00503, "postMarketPrice": 10.05, "postMarketChange": 0.1, "regularMarketChange": 0.71, "regularMarketDayRange": "9.0 - 10.23", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2875408, "fiftyTwoWeekLowChange": 3.5899997, "fiftyTwoWeekLowChangePercent": 0.56446534, "fiftyTwoWeekRange": "6.36 - 47.45", "fiftyTwoWeekHighChange": -37.5, "fiftyTwoWeekHighChangePercent": -0.79030555, "fiftyTwoWeekChangePercent": -76.768616, "earningsTimestamp": 1746703800, "earningsTimestampStart": 1754915400, "earningsTimestampEnd": 1754915400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.61, "epsForward": -3.16, "epsCurrentYear": -3.84625, "priceEpsCurrentYear": -2.5869353, "fiftyDayAverageChange": -1.0552006, "fiftyDayAverageChangePercent": -0.095882, "twoHundredDayAverageChange": -7.3432245, "twoHundredDayAverageChangePercent": -0.42463017, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-17", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "displayName": "Dyne Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]